✦ LIBER ✦

Efficacy and safety of levodopa with entacapone in Parkinson's disease patients suboptimally controlled with levodopa alone, in daily clinical practice: an international, multicentre, open-label study

✍ Scribed by Oscar Gershanik; Murat Emre; Gudrun Bernhard; Dirk Sauer

Book ID: 117449181
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 246 KB
Volume: 27
Category: Article
ISSN: 0278-5846
DOI: 10.1016/s0278-5846(03)00156-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Direct switch from levodopa/benserazide

Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson’s disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study

✍ Karla Eggert; Örjan Skogar; Khaled Amar; Liisa Luotonen; Mikko Kuoppamäki; Mika 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 335 KB

An open-label, multicentre clinical tria

An open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease

✍ M. M. Pinter; A. W. F. Rutgers; E. Hebenstreit; on behalf of the the study cente 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 198 KB

Efficacy and safety of tolcapone in levo

Efficacy and safety of tolcapone in levodopa-treated Parkinson's disease patients with “wearing-off” phenomenon: a multicentre, double-blind, randomized, placebo-controlled trial

✍ V. V. Myllylä; M. Jackson; J. P. Larsen; H. Baas; Tolcapone International Parkin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

Combining entacapone with levodopa/DDCI

Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson’s Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study

✍ M. Onofrj; A. Thomas; F. Vingerhoets; W. Martin; S. Giménez-Roldán; J.-P. Azulay 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 292 KB

Efficacy and safety of donepezil over 3

Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease

✍ A. Burns; S. Gauthier; C. Perdomo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective This 132‐week, open‐label extension study assessed the long‐term efficacy and safety of donepezil in 579 patients with mild to moderate Alzheimer's disease (AD) who had previously participated in a 24‐week double‐blind study of 5 or 10 mg/day donepezil __vs__ placebo. ##

2.211 The SENSE study: An open-label, si

2.211 The SENSE study: An open-label, single-arm, multicentre, 6-week study evaluating the efficacy and safety of levodopa/carbidopa/entacapone (Stavelo) in Parkinson's disease patients experiencing early re-emergence of symptoms due to wearing-off with conventional medication

✍ W.H. Oertel; K. Eggert; Ö. Skogar; K. Amar; L. Luotonen; H. Nissinen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 54 KB